In another signal of the deepening relationship between the pharma and AI sectors, Novartis chief executive Vas Narasimhan ...
Parkinson’s disease (PD) is entering a pivotal phase. For decades, treatment has centred on dopamine replacement to manage ...
Japanese pharma group Daiichi Sankyo has reached a deal to sell its consumer healthcare division to food and beverage giant ...
Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to ...
The Michael J Fox Foundation for Parkinson's Research (MJFF) has started working with Swiss biotech Biognosys on a project ...
The FDA may have approved Eli Lilly's oral weight-loss drug Foundayo in record time, but it still needs to see more safety ...
Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that it says brings together computational ...
For too long, MASLD care has relied on a narrow playbook: lifestyle advice, routine monitoring, and waiting for signs of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results